Current and Future Roles of Targeted Therapy and Immunotherapy in Advanced Melanoma

por Olszanski, Anthony J.
Publicado 2014

Evolving Paradigms in Melanoma Therapy

por Olszanski, Anthony J., Hoffner, Brianna W.
Publicado 2016

Advances in the Use of Immunotherapy in Oncology

por Olszanski, Anthony J., Zitella, Laura J.
Publicado 2017

Creating Clarity in Metastatic Melanoma: Optimizing Treatment and Improving Outcomes

por Viereck, Amanda M., Olszanski, Anthony J.
Publicado 2020

Immune Checkpoint Inhibitor–Based Therapy as a Backbone in Cancer Treatment

por Rubin, Krista M., Olszanski, Anthony J.
Publicado 2020

Donor Transmission of Melanoma Following Renal Transplant

por Chen, Kathryn T., Olszanski, Anthony, Farma, Jeffrey M.
Publicado 2012

Autoimmune inner ear disease in a melanoma patient treated with pembrolizumab

por Zibelman, Matthew, Pollak, Natasha, Olszanski, Anthony J
Publicado 2016

Feasibility and safety of targeting mitochondria for cancer therapy – preclinical characterization of gamitrinib, a first-in-class, mitochondriaL-targeted small molecule Hsp90 inhi...

por Hayat, Umar, Elliott, Gary T., Olszanski, Anthony J., Altieri, Dario C.
Publicado 2022

Impact of an alternative steroid on the relative bioavailability and bioequivalence of a novel versus the originator formulation of abiraterone acetate

por Hussaini, Azra, Olszanski, Anthony J., Stein, Cy A., Bosch, Bill, Nemeth, Paul
Publicado 2017

Metastatic Melanoma With Leptomeningeal Disease

por Marinova, Amanda M., Reilly, Jennifer L., Wong, Victoria, Weiss, Stephanie, Olszanski, Anthony J.
Publicado 2021

Pilot Study of ONCOS-102 and Pembrolizumab: Remodeling of the Tumor Microenvironment and Clinical Outcomes in Anti–PD-1–Resistant Advanced Melanoma

por Shoushtari, Alexander N., Olszanski, Anthony J., Nyakas, Marta, Hornyak, Thomas J., Wolchok, Jedd D., Levitsky, Victor, Kuryk, Lukasz, Hansen, Thomas B., Jäderberg, Magnus
Publicado 2023

Electrocardiographic Characterization of Ramucirumab on the Corrected QT Interval in a Phase II Study of Patients With Advanced Solid Tumors

por Olszanski, Anthony J., Smith, David C., Camacho, Luis H., Thompson, John, Ramalingam, Suresh S., Harvey, R. Donald, Campos, Luis, Ferry, David, Tang, Shande, Gao, Ling, Safran, Howard
Publicado 2016

Phase I dose-escalation study of cabazitaxel administered in combination with gemcitabine in patients with metastatic or unresectable advanced solid malignancies

por Rixe, Olivier, Puzanov, Igor, LoRusso, Patricia M., Cohen, Roger B., Morris, John C., Olowokure, Olugbenga O., Yin, Jian Y., Doroumian, Séverine, Shen, Liji, Olszanski, Anthony J.
Publicado 2015

Phase 1/2 study of epacadostat in combination with ipilimumab in patients with unresectable or metastatic melanoma

por Gibney, Geoffrey T., Hamid, Omid, Lutzky, Jose, Olszanski, Anthony J., Mitchell, Tara C., Gajewski, Thomas F., Chmielowski, Bartosz, Hanks, Brent A., Zhao, Yufan, Newton, Robert C., Maleski, Janet, Leopold, Lance, Weber, Jeffrey S.
Publicado 2019

Phase I trial of ATM inhibitor M3541 in combination with palliative radiotherapy in patients with solid tumors

por Waqar, Saiama N., Robinson, Clifford, Olszanski, Anthony J., Spira, Alexander, Hackmaster, Melissa, Lucas, Luisa, Sponton, Laura, Jin, Hulin, Hering, Ursula, Cronier, Damien, Grinberg, Marianna, Seithel-Keuth, Annick, Diaz-Padilla, Ivan, Berlin, Jordan
Publicado 2022

Author Correction: Phase I trial of ATM inhibitor M3541 in combination with palliative radiotherapy in patients with solid tumors

por Waqar, Saiama N., Robinson, Clifford, Olszanski, Anthony J., Spira, Alexander, Hackmaster, Melissa, Lucas, Luisa, Sponton, Laura, Jin, Hulin, Hering, Ursula, Cronier, Damien, Grinberg, Marianna, Seithel-Keuth, Annick, Diaz-Padilla, Ivan, Berlin, Jordan
Publicado 2022

Mogamulizumab in Combination with Nivolumab in a Phase I/II Study of Patients with Locally Advanced or Metastatic Solid Tumors

por Hong, David S., Rixe, Olivier, Chiu, Vi K., Forde, Patrick M., Dragovich, Tomislav, Lou, Yanyan, Nayak-Kapoor, Asha, Leidner, Rom, Atkins, James N., Collaku, Agron, Fox, Floyd E., Marshall, Margaret A., Olszanski, Anthony J.
Publicado 2022

Molecular profiling of melanoma brain metastases compared to primary cutaneous melanoma and to extracranial metastases

por In, Gino K., Poorman, Kelsey, Saul, Michelle, O’Day, Steven, Farma, Jeffrey M., Olszanski, Anthony J., Gordon, Michael S., Thomas, Jacob S., Eisenberg, Burton, Flaherty, Lawrence, Weise, Amy, Daveluy, Steven, Gibney, Geoffrey, Atkins, Michael B., Vanderwalde, Ari
Publicado 2020

Epacadostat Plus Pembrolizumab in Patients With Advanced Solid Tumors: Phase I Results From a Multicenter, Open-Label Phase I/II Trial (ECHO-202/KEYNOTE-037)

por Mitchell, Tara C., Hamid, Omid, Smith, David C., Bauer, Todd M., Wasser, Jeffrey S., Olszanski, Anthony J., Luke, Jason J., Balmanoukian, Ani S., Schmidt, Emmett V., Zhao, Yufan, Gong, Xiaohua, Maleski, Janet, Leopold, Lance, Gajewski, Thomas F.
Publicado 2018

Phase 1 study of the pan-RAF inhibitor tovorafenib in patients with advanced solid tumors followed by dose expansion in patients with metastatic melanoma

por Rasco, Drew W., Medina, Theresa, Corrie, Pippa, Pavlick, Anna C., Middleton, Mark R., Lorigan, Paul, Hebert, Chris, Plummer, Ruth, Larkin, James, Agarwala, Sanjiv S., Daud, Adil I., Qiu, Jiaheng, Bozon, Viviana, Kneissl, Michelle, Barry, Elly, Olszanski, Anthony J.
Publicado 2023